Health-related Quality of Life and Psychosocial Aspects of Diabetes Technology (Insulin Pumps)

Sponsor
Ain Shams University (Other)
Overall Status
Completed
CT.gov ID
NCT04756011
Collaborator
(none)
60
1
10.6
5.7

Study Details

Study Description

Brief Summary

This study will be prospective comparative trial comparing between insulin pumps vs Multiple daily injections (MDI) in treatment of type 1 diabetes mellitus (T1DM) in terms of health- related quality of life (HRQL) and efficacy of glycemic control (HbA1c level )

Hypothesis:

Type 1 diabetes is characterized by autoimmune destruction of insulin-secreting pancreatic b cells leading to disturbed glucose regulation and overt hyperglycemia which leads to variable consequences and complication. Consequently, individuals with type 1 diabetes have a lifelong dependency on insulin replacement therapy.

Aim of the Work:

To compare the psychosocial impact of insulin pumps versus multiple daily injections in treatment of type 1 diabetes mellitus (Via questionnaire) in terms of health-related quality of life and efficacy of glycemic control (HbA1c level).

Condition or Disease Intervention/Treatment Phase
  • Other: Health related quality of life

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
60 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Aspects of Diabetes Technology (Insulin Pumps) Children Perspective, a Cross - Sectional Study
Actual Study Start Date :
Mar 15, 2020
Actual Primary Completion Date :
Jan 17, 2021
Actual Study Completion Date :
Feb 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Group A (insulin pump)

30 patients who are on insulin pump.

Other: Health related quality of life
Confidence in diabetes self care questionnaire the socioeconomic level of the family scale MINI-KID the Peds-QL

Group B (MDI)

30 patients who are on multiple daily injection.

Other: Health related quality of life
Confidence in diabetes self care questionnaire the socioeconomic level of the family scale MINI-KID the Peds-QL

Outcome Measures

Primary Outcome Measures

  1. Confidence in diabetes self care questionnaire (CIDS) [10 min]

    the CIDS scale, assessment included HbA1c, emotional distress, fear of hypoglycemia, self-esteem, anxiety, depression, and self-care behavior. The CIDS scale is a reliable and valid measure of diabetes-specific self-efficacy for use in patients with type 1 diabetes. High psychometric similarity allows for cross-cultural comparisons.

  2. socioeconomic level of the family scale [5 minutes]

    Assessment of family socioeconomic standard

  3. MINI-KID (Mini International Neuropsychiatric Interview ) [25 minutes]

    Mini International Neuropsychiatric Interview for Children and Adolescents

  4. Evaluation of health-related quality of life (HRQL) [5 minutes]

    HRQL was measured by the Peds-QL 4.0 11,22. The 23-item Peds-QL 4.0 generic core scales encompass (a) physical functioning (eight items), (b) emotional functioning (five items), (c) social functioning (five items), and (d) school functioning (five items). The physical health summary score (eight items) is the same as the physical functioning scale. To create the psychosocial health summary score (15 items), the mean is computed as the sum of the items divided by the number of items answered in the emotional, social, and school functioning scales.

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 1.Type 1 diabetes mellitus.

  • 2.Patients who are on insulin pumps must be for at least 3 months on them

Exclusion Criteria:
    1. Other types of DM e.g., T2DM, MODY.
    1. Patients with other comorbidities; cardiac, renal, neurological, hepatic ….etc.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ain shams University Cairo Abbasia Egypt 11517

Sponsors and Collaborators

  • Ain Shams University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ain Shams University
ClinicalTrials.gov Identifier:
NCT04756011
Other Study ID Numbers:
  • Health related quality of life
First Posted:
Feb 16, 2021
Last Update Posted:
Feb 23, 2021
Last Verified:
Feb 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ain Shams University

Study Results

No Results Posted as of Feb 23, 2021